Europe Malaria Treatment Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Treatment (Generic Drugs, Originators, Vaccines, and Others), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)


No. of Pages: 87    |    Report Code: TIPRE00025038    |    Category: Life Sciences

Europe Malaria Treatment Market
Buy Now

The Europe malaria treatment market was valued at US$ 451.69 million in 2022 and is expected to reach US$ 3,060.97 million by 2030; it is estimated to grow at a CAGR of 27.0% from 2022 to 2030.

Extending Pipeline of New Drugs and Vaccines Drive Europe Malaria Treatment Market

Antimicrobial resistance can put the public at risk of many diseases, such as malaria. To overcome this challenge, the R&D of new medicines is considered the best strategy; as a result, the antimalarial pipeline is becoming increasingly robust. Public-private partnerships are accelerating research activities related to the treatment of malaria. For instance, Medicines for Malaria Venture (MMV), a nonprofit organization, works with numerous pharmaceutical companies to reduce the burden of malaria by developing novel treatment options.

A few antimalarial that are under clinical development are mentioned in the table below:

Malaria Drugs/Vaccine/Compounds Under Clinical Development

 

Drug

Developer

Clinical Trial Stage

Artefenomel

Sanofi

Phase IIb

KAE609

Novartis AG

Phase IIb

KAF156

Novartis AG

Phase IIb

DSM265

Takeda Pharmaceutical Company

Phase IIa

SANARIA PfSPZ-GA1

Sanaria

Phase II

SANARIA PfSPZ Vaccine – Radiation Attenuated PfSPZ Vaccine

Sanaria

Phase II

SANARIA PfSPZ-CVac

Sanaria

Phase II

MSP3-CRM-Vac4All

Vac4All

Phase I

Liver-Stage Antigen-3 (LSA3)

Vac4All

Phase IIa

Source: Company Website, The Insight Partners Analysis

Therefore, the growing number of antimalarial and drugs/vaccines that are under clinical development are expected to boost the market growth in the future.

Europe Malaria Treatment Market Overview

 

According to a surveillance report by ECDC, France reported the highest number of malaria cases in 2020. In 2020, France reported 1,007 confirmed malaria cases. Nearly all the cases reported by EU/EEA countries in 2020 were diagnosed in people traveling to France from other countries; these mostly included individuals linked to travel routes from West Africa. In France, P. falciparum is responsible for almost all severe cases and deaths in travelers. Many research organizations are working toward developing new approaches to eliminate malaria in France. For example, teams at the Institut Pasteur are dedicated to malaria research aiming to develop vaccines. This research is vital in finding new ways of fighting malaria. The Institute Pasteur is also taking part in a major European program named EVIMalaR, which involves 17 research institutes and universities from 7 European countries, and partners from 3 African countries. Such collaborative efforts toward malaria elimination are driving the growth of the malaria treatment market in France.

 

Europe Malaria Treatment Market Revenue and Forecast to 2030 (US$ Million)

Europe Malaria Treatment Market Revenue and Forecast to 2030 (US$ Million)
Get more information on this report

Europe Malaria Treatment Strategic Insights

Strategic insights for the Europe Malaria Treatment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/europe-malaria-treatment-market-strategic-framework.webp
Get more information on this report

Europe Malaria Treatment Report Scope

Report Attribute Details
Market size in 2022 US$ 451.69 Million
Market Size by 2030 US$ 3,060.97 Million
Global CAGR (2022 - 2030) 27.0%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Treatment
  • Generic Drugs
  • Originators
  • Vaccines
By Route of Administration
  • Oral
  • Parenteral
By Distribution Channel
  • Direct Tender
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • Lupin Ltd
  • Get more information on this report

    Europe Malaria Treatment Regional Insights

    The geographic scope of the Europe Malaria Treatment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/europe-malaria-treatment-market-geography.webp
    Get more information on this report

     

    Europe Malaria Treatment Market Segmentation

     

    The Europe malaria treatment market is segmented based on treatment, route of administration, distribution channel, and country. Based on treatment, the Europe malaria treatment market is segmented into generic drugs, originators, vaccines, and others. The generic drugs segment held the largest market share in 2022.

    In terms of route of administration, the Europe malaria treatment market is bifurcated into oral and parenteral. The oral segment held a larger market share in 2022.

    By distribution channel, the Europe malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

    Based on country, the Europe malaria treatment market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. France dominated the Europe malaria treatment market share in 2022.

    Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, and Lupin Ltd are some of the leading players operating in the Europe malaria treatment market.   

    The List of Companies - Europe Malaria Treatment Market

    1. Cipla Ltd
    2. Sun Pharmaceutical Industries Ltd
    3. Sanofi SA
    4. GSK Plc
    5. Novartis AG
    6. Pfizer Inc
    7. Lupin Ltd

    Frequently Asked Questions
    How big is the Europe Malaria Treatment Market?

    The Europe Malaria Treatment Market is valued at US$ 451.69 Million in 2022, it is projected to reach US$ 3,060.97 Million by 2030.

    What is the CAGR for Europe Malaria Treatment Market by (2022 - 2030)?

    As per our report Europe Malaria Treatment Market, the market size is valued at US$ 451.69 Million in 2022, projecting it to reach US$ 3,060.97 Million by 2030. This translates to a CAGR of approximately 27.0% during the forecast period.

    What segments are covered in this report?

    The Europe Malaria Treatment Market report typically cover these key segments-

    • Treatment (Generic Drugs, Originators, Vaccines)
    • Route of Administration (Oral, Parenteral)
    • Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

    What is the historic period, base year, and forecast period taken for Europe Malaria Treatment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Malaria Treatment Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Europe Malaria Treatment Market?

    The Europe Malaria Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • Lupin Ltd
  • Who should buy this report?

    The Europe Malaria Treatment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Malaria Treatment Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now